Bharti Airtel Declares Dividend Of Rs 16 Per Share

The total amount to be disbursed as dividend is around Rs 9,751 crore.

Bharti Airtel Ltd. recommended a final dividend of Rs 16 per fully paid-up equity share with face value of Rs 5 each for financial year 2025 (Photo: Vijay Sartape/NDTV Profit)

Bharti Airtel Ltd. recommended a final dividend of Rs 16 per fully paid-up equity share with a face value of Rs 5 each as well as for Rs 4 per partly paid-up equity share with a face value of Rs 5 each for financial year 2025.

The total amount to be disbursed as dividend is around Rs 9,751 crore. Retail investors who own up to 1.85% stake will receive a sum total of up to Rs 180 crore, according to an exchange filing on Tuesday.

Also Read: Q4 Results: Metropolis Health Earnings Miss Estimates; Dalmia Bharat Sugar Profit More Than Doubles

Bharti Airtel's saw a 25% decrease in consolidated net profit for the fourth quarter of fiscal 2025, but surpassed analysts' expectations.

The telecommunication firm announced a net profit of Rs 11,022 crore for the quarter ended March 31, 2025. This exceeded the Rs 6,509-crore forecast by analysts monitored by Bloomberg.

Airtel Q4 FY25 Earnings Highlights (Consolidated, QoQ)

  • Revenue rose 6% to Rs 47,876 crore versus Rs 45,129 crore (Bloomberg estimate: Rs 48,502 crore).

  • Ebitda profit up 10% to Rs 27,009 crore versus Rs 24,597 crore (Estimate: Rs 26,803 crore).

  • Margin at 56.4% versus 54.5% (Estimate: 55.3%).

  • Net profit fell 25% to Rs 11,022 crore versus Rs 14,781.2 crore (Estimate: Rs 6,509 crore).

  • ARPU is at flat at Rs 245.

Share Price

Before the quarterly results were declared, Bharti Airtel's stock closed 2.68% lower at Rs 1,820.6 apiece on NSE, compared to a 1.39% decline in the benchmark index Nifty 50.

It has risen 41.58% in the last 12 months and 14.67% on a year-to-date basis.

Twenty-nine out of the 34 analysts tracking the company have a 'buy' rating on the stock, three recommend a 'hold' and two suggest a 'sell', according to Bloomberg data. The 12-month analysts' consensus target price on the stock is Rs 1,885.8, implying a upside of 3.6%.

Also Read: Q4 Results: Metropolis Health Earnings Miss Estimates; Dalmia Bharat Sugar Profit More Than Doubles

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
WRITTEN BY
Prajwal Jayaraj
Prajwal Jayaraj covers business news for NDTV Profit. He holds a postgradua... more
GET REGULAR UPDATES